|
Market Closed -
Euronext Bruxelles
23:55:00 04/09/2026 HKT
|
Pre-market 13:18:09 | |||
| 210.60 EUR | -4.58% |
|
210.05 | -0.26% |
| 09-01 | Global pharma companies that have publicly announced Trump drug pricing agreements | RE |
| 09-01 | White House Cuts Deal to Lower Prescription Drug Prices With Nine Companies | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 46.66B | |||||
| 82.65B | |||||
| 60.24B | |||||
| 58.11B | - | ||||
| 49.68B | |||||
| 32.63B |
- Stock Market
- Stocks
- UCB Stock
- Charts UCB
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
